Hunt Hazel 4
4 · CORCEPT THERAPEUTICS INC · Filed Jan 12, 2024
Insider Transaction Report
Form 4
Hunt Hazel
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2024-01-08$3.02/sh+50,000$151,000→ 123,146 total - Tax Payment
Common Stock
2024-01-08$27.46/sh−29,792$818,088→ 93,354 total - Exercise/Conversion
Stock Option (right to buy)
2024-01-08−50,000→ 0 totalExercise: $3.02Exp: 2024-02-06→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 6, 2024.
- [F2]Fully exercisable.